Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Eur J Gynaecol Oncol ; 32(4): 455-6, 2011.
Article in English | MEDLINE | ID: mdl-21941978

ABSTRACT

PURPOSE OF INVESTIGATION: A rare case of increasing CA 125 and CA 19-9 levels increasing in a woman with adenomyoma is described. METHODS: A 39-year-old nullipara woman with CA 125 = 1,796 U/ml and CA 19-9 = 177 U/ml was submitted to abdominal and pelvic MRI, gastric endoscopy, colonoscopy, hysteroscopy, pelvic Doppler and PET scan. None of the exams revealed any apparent malignant disease. RESULTS: Six months of gonadotropin releasing hormone agonist treatment reduced CA 125 and CA 19-9 levels. However, after contraceptive pill use the markers were again elevated, and a laparoscopic hysterectomy was performed, and normal CA 125 and CA 19-9 levels were achieved. CONCLUSIONS: Adenomyoma may be associated with high levels of CA 125 and CA 19-9.


Subject(s)
Adenomyoma/diagnosis , Adenomyoma/therapy , CA-125 Antigen/blood , CA-19-9 Antigen/blood , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/therapy , Adenomyoma/blood , Adenomyoma/drug therapy , Adenomyoma/surgery , Adult , Dose-Response Relationship, Drug , Female , Gonadotropin-Releasing Hormone/agonists , Humans , Ovarian Neoplasms/blood , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/surgery , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...